Dealmaker’s Diary: The 12-Month Money Move That Could Double Your Portfolio
Big money flips stocks yearly now, not every decade. By using the same timeline, we’ve generated 27% returns while others hold deteriorating positions.
Dealmaker’s Diary: The Rare Disease Fighter Trading at Bargain Prices
This biotech generates positive cash flow while others burn money. At 25x forward earnings, you’re getting tomorrow’s genetic breakthroughs at a discount.
This Payments Processor Just Had an AI-Driven Breakout
This payments processor shows strong fundamentals with 12.5% CROCI, a P/E of 13.7x, and promising AI integration.
Why My System Loves This Insurance Powerhouse
With near-zero volatility and strong CROCI of 11.7x, Marsh McLennan offers exceptional stability plus AI innovation even during market turbulence.
Monday Takeaways: Why You Should Embrace This Market Pullback
Trading through tough times with an analytical approach
Dealmaker’s Diary: Timing Matters for This Unusual Energy Play
This stock isn’t your typical energy play. Alpesh’s unusual timing strategy for this $3B natural gas provider helps dodge volatility while capturing upside.
Buy This, Not That: Three Reader Stocks… Only One Winner
One stock is in a perfect buy zone… while another’s speculation runs too hot… and the third can’t turn gold into profits.
Build and Protect More Than Just Your Wealth With Crypto
Bitcoin is not just an investment. It’s a stake in a more equitable and liberated financial future.
Add These Crypto “Blue Chips” to Your Portfolio Today
We’re in the middle of a major crypto bull market. But don’t miss the big picture. Even owning these two crypto “blue chips” could be life-changing.
The Market Metric That Predicts Trouble Before It Arrives
Credit spreads act as market truth-tellers. Today’s tight spreads suggest investors remain confident despite economic headwinds – a surprising vote of optimism.